Emergo Therapeutics, Inc. — Form D
Emergo Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-09. The offering totals $1.5M, of which $500K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-05-09
- Form: D
- Accession: 0001741198-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $500K
- Remaining: $1.0M
- Investors: 2
- Date of first sale: 2022-04-26
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-444966
Issuer
- Name: Emergo Therapeutics, Inc.
- CIK: 0001741198
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 6208 FAYETTEVILLE ROAD #104, DURHAM, NC, 27713
- Phone: 919-599-4381
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| John E. Bailey, Jr. | Director | Durham, NC |
| Robert Helmedag | Director | Plano, TX |
| Moise Khayrallah | Director | Durham, NC |
| Margaret Powell | Director | Durham, NC |
| Moise Khayrallah | Executive Officer | Durham, NC |
| Margaret E Powell | Director | Durham, NC |
| Robert E Helmedag | Director | Durham, NC |
| John E Bailey, Jr. | Director | Durham, NC |
| Robin Hyde-DeRuyscher | Director | Durham, NC |
| Robin Hyde-DeRuyscher | Executive Officer | Durham, NC |
Other filings by this issuer (3)
More